iReprogram Information

iReprogram, Inc. is a biotechnology company located in Ann Arbor, Michigan, USA, building a software platform for cell reprogramming across three modalities: direct reprogramming, induced pluripotent stem cells (iPSCs), and cell state conversion. Our interdisciplinary team across biology, mathematics, computer science and AI shares a single aim: to make cell state programmable. Powered by our patented algorithms, we predict the transcription factor combinations, dosages, and timing required to convert one cell type into a functional target. Our technology revolutionizes the frontiers of biological repair, driving patient-specific therapies for chronic degenerative conditions such as diabetes, Parkinson's, Alzheimer's, cancer, kidney disease, fibrosis, and aging with board applicability to make a meaningful impact on the lives of every human being.